Literature DB >> 18802336

Natural killer cells in allergic inflammation.

G Erten1, E Aktas, G Deniz.   

Abstract

Natural killer (NK) cells are large granular lymphocytes of the innate immune system that exert a potent function against infected and tumor cells. Although NK cells were originally defined by their capacity to lyse target cells and produce interferon-gamma without prior activation, recent studies showed that NK cells also display a potent regulatory function. They are activated or inhibited through the ligation of germline-encoded receptors and are involved in mediating cytotoxicity, producing cytokines and providing costimulation to cells of the adaptive immune system. NK cells play important roles in viral infections, autoimmunity, pregnancy, cancer and bone marrow transplantation, but little is known about the role of NK cells in allergy. Recent developments in the understanding of the role of human NK cells in allergy are overviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802336     DOI: 10.1159/000154856

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  4 in total

1.  Tumors induce the formation of suppressor endothelial cells in vivo.

Authors:  Jennifer Konopa Mulligan; M Rita I Young
Journal:  Cancer Immunol Immunother       Date:  2010-02       Impact factor: 6.968

2.  Natural killer cells in asthma.

Authors:  Khalil Karimi; Paul Forsythe
Journal:  Front Immunol       Date:  2013-06-21       Impact factor: 7.561

3.  Interleukin-28B dampens airway inflammation through up-regulation of natural killer cell-derived IFN-γ.

Authors:  Bailing Yan; Feng Chen; Lijun Xu; Yanshi Wang; Xuefu Wang
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

4.  Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.

Authors:  Hyun Gul Yang; Moon Cheol Kang; Tae Yoon Kim; Injung Hwang; Hyun Tak Jin; Young Chul Sung; Ki-Seong Eom; Sae Won Kim
Journal:  J Immunother Cancer       Date:  2019-05-24       Impact factor: 13.751

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.